COMMUNIQUÉS West-GlobeNewswire

Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy
09/10/2025
KNOXVILLE, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of independent preclinical research by Aru Narendran, [...]
Series A Round Valuation: ¥9 Billion: MEDIROM MOTHER Labs Inc. Decides to Make an Investment from Internal Investors
09/10/2025
TOKYO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Yoshio Uekusa; hereinafter “MOTHER Labs”), a subsidiary of MEDIROM Healthcare Technologies Inc. ( [...]
CDT Equity Inc. Announces Reverse Stock Split
09/10/2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-8 reverse stock split of [...]
Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer
09/10/2025
Global Phase III trial has enrolled and randomised over 170 patients, reaching an important milestone as this is above the amount needed to conduct the futility analysis Over 100 clinical sites across 24 countries now [...]
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
09/10/2025
CORAL GABLES, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing [...]
NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market
09/10/2025
SANTA ANA, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic
09/10/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, 9 [...]
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD
09/10/2025
Leading Expert on Targeted Drug-Delivery and Locoregional Cancer Therapies Strengthens RenovoRx’s Scientific Advisory Board LOS ALTOS, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “ [...]
CytoDyn to Present at the LD Micro Main Event XIX Investor Conference
09/10/2025
CFO Robert E. Hoffman to deliver company presentation on October 21, 2025 VANCOUVER, Washington, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology [...]
Iolyx Therapeutics Announces Upcoming Presentation at Eyecelerator 2025 and Poster at the American Academy of Ophthalmology Annual Meeting
09/10/2025
BURLINGAME, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Iolyx Therapeutics, a clinical-stage biotechnology company developing therapeutics at the intersection of ocular inflammation and autoimmunity, today announced that [...]
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
09/10/2025
Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development GLEN ALLEN, Va., Oct. 09, 2025 ( [...]
Digital Utilities Ventures Completes Acquisition and Name Change
09/10/2025
Planned uplist to OTCQB Venture Exchange, if approved will follow completion of audit and previously announced reverse split MANKATO, Minn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV [...]
Akari Therapeutics Files Two New Patents for Immuno-Oncology Mode of Action for Novel ADC Platform Utilizing Spliceosome Modulating Payload PH1
09/10/2025
BOSTON and LONDON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has filed [...]
Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
09/10/2025
With over 120 issued and pending patent applications, Autonomix is building a comprehensive, global IP portfolio in nerve-sensing and modulation Newly issued patent strengthens the Company’s strategic position in a [...]
Journal of Clinical Microbiology Studies Demonstrate Two Investigational Diagnostics Outperform Current Tests in Detecting Early Lyme Disease
09/10/2025
Studies utilize Bay Area Lyme Foundation’s Lyme Disease Biobank samples to point to promise of single-tier diagnostics to potentially transform early detection PORTOLA VALLEY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- [...]
Doheny Eye Institute Announces Upcoming Presentations at the American Academy of Ophthalmology 2025 Annual Meeting
09/10/2025
Doheny-UCLA clinician-scientists selected to deliver more than 25 presentations and talks PASADENA, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research [...]
Safety Shot, Inc. to Become Bonk, Inc., to Trade on Nasdaq Under New Ticker Symbol “BNKK”
09/10/2025
Rebranding Solidifies Company’s Full Strategic Transformation into the Premier Public Vehicle for the BONK Ecosystem SCOTTSDALE, AZ, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company”) [...]
Children's National Hospital receives $8 million grant from Gilbert Family Foundation to advance neurofibromatosis research
09/10/2025
The investment deepens a partnership to transform care for one of the most common genetic conditions in children Washington, DC, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Children’s National Hospital and the Gilbert Family [...]
Legend Senior Living® Grows Florida Footprint With Renaissance of North Tampa
09/10/2025
WICHITA, Kan., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living®, a nationally recognized senior living provider based in Wichita, KS, has announced the management of Renaissance North Tampa, expanding its Florida [...]

Pages